These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 23518378)

  • 21. Assessment of myocardial viability in chronic ischemic heart disease: current status.
    Rizzello V; Poldermans D; Bax JJ
    Q J Nucl Med Mol Imaging; 2005 Mar; 49(1):81-96. PubMed ID: 15724138
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of myocardial viability in ischemic heart disease by cardiac magnetic resonance imaging.
    Muellerleile K; Barmeyer A; Groth M; Lund GK
    Minerva Cardioangiol; 2008 Apr; 56(2):237-49. PubMed ID: 18319702
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of reversible myocardial dysfunction in chronic ischaemic heart disease: comparison of contrast-enhanced cardiovascular magnetic resonance and a combined positron emission tomography-single photon emission computed tomography imaging protocol.
    Kühl HP; Lipke CS; Krombach GA; Katoh M; Battenberg TF; Nowak B; Heussen N; Buecker A; Schaefer WM
    Eur Heart J; 2006 Apr; 27(7):846-53. PubMed ID: 16434414
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An indictment of the STICH trial: "True, true, and unrelated".
    Conte J
    J Heart Lung Transplant; 2010 May; 29(5):491-6. PubMed ID: 20382350
    [No Abstract]   [Full Text] [Related]  

  • 25. Viable myocardium: how much is enough?
    Salazar HP; Talano JV
    Echocardiography; 2005 Jan; 22(1):59-70. PubMed ID: 15660692
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Surgical ventricular restoration for ischemic cardiomyopathy; to further improve surgical outcomes].
    Yaku H; Okawa K; Doi K
    Kyobu Geka; 2011 Oct; 64(11):989-95. PubMed ID: 22111343
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Dobutamine stress magnetic resonance imaging (DS-MRI), a valuable tool for the diagnosis of ischemic heart disease].
    van Dijkman PR; Kuijpers TJ; Blom BM; van Herpen G
    Ned Tijdschr Geneeskd; 2002 Jul; 146(28):1327-32. PubMed ID: 12148221
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surgical ventricular restoration procedure: single-center comparison of Surgical Treatment of Ischemic Heart Failure (STICH) versus non-STICH patients.
    Goh S; Prior D; Newcomb A; McLellan A; Mack J; Callaghan S; Dimitriou J; Rosalion A; Nixon I; Yii M
    Ann Thorac Surg; 2013 Feb; 95(2):506-12. PubMed ID: 23245443
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myocardial Revascularization in Patients With Ischemic Cardiomyopathy: For Whom and How.
    Liga R; Colli A; Taggart DP; Boden WE; De Caterina R
    J Am Heart Assoc; 2023 Mar; 12(6):e026943. PubMed ID: 36892041
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The STICH Viability substudy].
    Menicanti L; Sicari R
    G Ital Cardiol (Rome); 2012 Nov; 13(11):705-9. PubMed ID: 23096578
    [No Abstract]   [Full Text] [Related]  

  • 31. The role of noninvasive imaging in coronary artery disease detection, prognosis, and clinical decision making.
    Dowsley T; Al-Mallah M; Ananthasubramaniam K; Dwivedi G; McArdle B; Chow BJ
    Can J Cardiol; 2013 Mar; 29(3):285-96. PubMed ID: 23357601
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myocardial viability in chronic ischemic cardiomyopathy: similarities and discordance of different diagnostic approaches.
    Weissman G; Asch FM
    J Cardiovasc Transl Res; 2009 Mar; 2(1):24-9. PubMed ID: 20559966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Current Role of Viability Imaging to Guide Revascularization and Therapy Decisions in Patients With Heart Failure and Reduced Left Ventricular Function.
    Kandolin RM; Wiefels CC; Mesquita CT; Chong AY; Boland P; Glineur D; Sun L; Beanlands RS; Mielniczuk LM
    Can J Cardiol; 2019 Aug; 35(8):1015-1029. PubMed ID: 31376903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of myocardial viability by PET.
    Khalaf S; Chamsi-Pasha M; Al-Mallah MH
    Curr Opin Cardiol; 2019 Sep; 34(5):466-472. PubMed ID: 31393420
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myocardial viability: it is still alive.
    Lim SP; Mc Ardle BA; Beanlands RS; Hessian RC
    Semin Nucl Med; 2014 Sep; 44(5):358-74. PubMed ID: 25234080
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic and imaging considerations: role of viability.
    Senior R
    Heart Fail Rev; 2006 Jun; 11(2):125-34. PubMed ID: 16937031
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Revascularization in heart failure in the post-STICH era.
    Jha S; Flamm SD; Kwon DH
    Curr Heart Fail Rep; 2013 Dec; 10(4):365-72. PubMed ID: 24142670
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The STICH trial (Surgical Treatment for Ischemic Heart Failure): mode-of-death results.
    Carson P; Wertheimer J; Miller A; O'Connor CM; Pina IL; Selzman C; Sueta C; She L; Greene D; Lee KL; Jones RH; Velazquez EJ;
    JACC Heart Fail; 2013 Oct; 1(5):400-8. PubMed ID: 24621972
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myocardial viability testing: still viable after stich?
    Bonow RO; Holly TA
    J Nucl Cardiol; 2011 Dec; 18(6):991-4. PubMed ID: 21913051
    [No Abstract]   [Full Text] [Related]  

  • 40. Association of Inducible Myocardial Ischemia With Long-Term Mortality and Benefit From Coronary Artery Bypass Graft Surgery in Ischemic Cardiomyopathy: Ten-Year Follow-Up of the STICH Trial.
    O'Fee K; Panza JA; Brown DL
    Circulation; 2021 Jan; 143(2):205-207. PubMed ID: 33428429
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.